Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 8
2005 3
2006 6
2007 6
2008 7
2009 14
2010 14
2011 16
2012 24
2013 32
2014 30
2015 53
2016 67
2017 66
2018 76
2019 104
2020 119
2021 129
2022 160
2023 173
2024 178
2025 69

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,219 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean mingming, zhang (5 results)?
The emerging role of ferroptosis in inflammation.
Sun Y, Chen P, Zhai B, Zhang M, Xiang Y, Fang J, Xu S, Gao Y, Chen X, Sui X, Li G. Sun Y, et al. Among authors: zhang m. Biomed Pharmacother. 2020 Jul;127:110108. doi: 10.1016/j.biopha.2020.110108. Epub 2020 Mar 29. Biomed Pharmacother. 2020. PMID: 32234642 Free article. Review.
Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL.
Zhang J, Hu Y, Yang J, Li W, Zhang M, Wang Q, Zhang L, Wei G, Tian Y, Zhao K, Chen A, Tan B, Cui J, Li D, Li Y, Qi Y, Wang D, Wu Y, Li D, Du B, Liu M, Huang H. Zhang J, et al. Among authors: zhang m. Nature. 2022 Sep;609(7926):369-374. doi: 10.1038/s41586-022-05140-y. Epub 2022 Aug 31. Nature. 2022. PMID: 36045296 Free PMC article. Clinical Trial.
CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia.
Hu Y, Zhou Y, Zhang M, Ge W, Li Y, Yang L, Wei G, Han L, Wang H, Yu S, Chen Y, Wang Y, He X, Zhang X, Gao M, Yang J, Li X, Ren J, Huang H. Hu Y, et al. Among authors: zhang m. Clin Cancer Res. 2021 May 15;27(10):2764-2772. doi: 10.1158/1078-0432.CCR-20-3863. Epub 2021 Feb 24. Clin Cancer Res. 2021. PMID: 33627493 Clinical Trial.
Therapeutic Inhibition of LincRNA-p21 Protects Against Cardiac Hypertrophy.
Wang Y, Zhang M, Wang R, Lin J, Ma Q, Guo H, Huang H, Liang Z, Cao Y, Zhang X, Lu YW, Liu J, Xiao F, Yan H, Dimitrova N, Huang ZP, Mably JD, Pu WT, Wang DZ. Wang Y, et al. Among authors: zhang m. Circ Res. 2024 Jul 19;135(3):434-449. doi: 10.1161/CIRCRESAHA.123.323356. Epub 2024 Jun 12. Circ Res. 2024. PMID: 38864216
A Reporting Tool for Practice Guidelines in Health Care: The RIGHT Statement.
Chen Y, Yang K, Marušic A, Qaseem A, Meerpohl JJ, Flottorp S, Akl EA, Schünemann HJ, Chan ES, Falck-Ytter Y, Ahmed F, Barber S, Chen C, Zhang M, Xu B, Tian J, Song F, Shang H, Tang K, Wang Q, Norris SL; RIGHT (Reporting Items for Practice Guidelines in Healthcare) Working Group. Chen Y, et al. Among authors: zhang m. Ann Intern Med. 2017 Jan 17;166(2):128-132. doi: 10.7326/M16-1565. Epub 2016 Nov 22. Ann Intern Med. 2017. PMID: 27893062
Pathogenetic mechanisms of septic cardiomyopathy.
Wang R, Xu Y, Fang Y, Wang C, Xue Y, Wang F, Cheng J, Ren H, Wang J, Guo W, Liu L, Zhang M. Wang R, et al. Among authors: zhang m. J Cell Physiol. 2022 Jan;237(1):49-58. doi: 10.1002/jcp.30527. Epub 2021 Jul 18. J Cell Physiol. 2022. PMID: 34278573 Review.
1,219 results